Hua Jian Medical (01931.HK) plans to spend up to 50 million Hong Kong dollars to repurchase a maximum of 30 million shares.

Wisdom Financial News APP, Huajian Medical (01931.HK) announced that the company will, depending on market conditions and with the authorization for repurchase, repurchase shares on the open market for a period of one year starting from the date of this announcement. To avoid doubts, any share repurchase conducted after the company's annual shareholders meeting held on June 30, 2025 will be subject to shareholder approval of the repurchase authorization at the 2025 annual shareholders meeting.